Evidence map›Paper›PMID 40313477›Full record

ArticleIn silico pharmacology2025

Molecular Docking and anti-MRSA effects of bioactive compounds from

M Vinutha, A Manikandan, R N Lakshmikanth, S Shravani, B Divyashree, K Aishwarya, M M Nagaraj

Abstract read
In one paragraph

Article in In silico pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

M VinuthaDepartment of Biotechnology, M.S Ramaiah College of Arts, Science and Commerce, Bangalore, 54 India.
A ManikandanCenter for Global Health Research, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai, 602105 India.ORCID 0000-0002-7065-5884
R N LakshmikanthDepartment of Biotechnology, M.S Ramaiah College of Arts, Science and Commerce, Bangalore, 54 India.
S ShravaniDepartment of Biotechnology, M.S Ramaiah College of Arts, Science and Commerce, Bangalore, 54 India.
B DivyashreeDepartment of Biotechnology, M.S Ramaiah College of Arts, Science and Commerce, Bangalore, 54 India.
K AishwaryaDepartment of Biotechnology, M.S Ramaiah College of Arts, Science and Commerce, Bangalore, 54 India.
M M NagarajDepartment of Biotechnology, M.S Ramaiah College of Arts, Science and Commerce, Bangalore, 54 India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Molecular docking is an effective tool for screening bioactive compounds based on molecular mechanistic values. Efforts were taken to identify and screen plant secondary metabolites against Methicillin-Resistant Supplementary Information: The online version contains supplementary material available at 10.1007/s40203-025-00334-4.

Indexed as

CymbopogonMD simulationsMolecular DockingMRSAPBP2aRAPD

Identifiers

PMID40313477
PMCPMC12040786

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.